Acarbose-metformin is more effective in glycemic variability control than repaglinide-metformin in T2DM patients inadequately controlled with metformin: a retrospective cohort study
Background Acarbose and repaglinide are widely used either by themselves or in combination with other medications. However, their efficacy in diabetes control has not been compared when used in combination with metformin. Methods The present study aimed to compare their effects on glycemic variabili...
Main Authors: | Guoli Du, Wanrun Xie, Yinxia Su, Yao Ma, Xiaoming Gao, Sheng Jiang, Huazheng Liang |
---|---|
Format: | Article |
Language: | English |
Published: |
PeerJ Inc.
2020-10-01
|
Series: | PeerJ |
Subjects: | |
Online Access: | https://peerj.com/articles/9905.pdf |
Similar Items
-
A Histomorphological Comparative Effects of Metformin, Pioglitazone, Repaglinide and Acarbose on Polycystic Ovary in Mice
by: fariba noori, et al.
Published: (2020-04-01) -
Repaglinide/metformin fixed-dose combination to improve glycemic control in patients with type 2 diabetes: an update
by: Moses R
Published: (2010-05-01) -
Short-term efficacy and safety of repaglinide versus glimepiride as augmentation of metformin in treating patients with type 2 diabetes mellitus
by: Xie J, et al.
Published: (2019-04-01) -
Evaluation of Serum Vaspin and Chemerin Levels in Type 2 Diabetic and Treated with Anti Diabetic Drugs Metformin and Acarbose in Rats
by: Seyed Mohammad Ali Ghaffari, et al.
Published: (2015-04-01) -
Evaluation of Serum Vaspin and Chemerin Levels in Type 2 Diabetic and Treated with Anti Diabetic Drugs Metformin and Acarbose in Rats
by: Seyed Mohammad Ali Ghaffari, et al.
Published: (2015-05-01)